INVO Fertility (IVF) Capital Expenditures (2016 - 2025)

INVO Fertility (IVF) has 9 years of Capital Expenditures data on file, last reported at $8062.0 in Q3 2025.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to $8062.0 in Q3 2025; TTM through Sep 2025 was $110463.0, a 38.57% decrease from a year earlier, with the FY2024 full-year figure at $183703.0, down 58.69% from the prior year.
• Capital Expenditures for Q3 2025 stood at $8062.0, down from $8877.0 in the prior quarter.
• Over the last five years, Capital Expenditures for IVF reached as high as $108217.0 in Q3 2023 and fell as low as -$328537.0 in Q4 2021.
• Historically, Capital Expenditures has averaged $6212.1 across 5 years, with a median of $8877.0 in 2025.
• Across the five-year window, Capital Expenditures tumbled 1243.41% in 2021 and surged 55655.56% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at -$328537.0 in 2021, then jumped by 99.96% to -$135.0 in 2022, then jumped by 55655.56% to $75000.0 in 2023, then gained by 5.17% to $78874.0 in 2024, then slumped by 89.78% to $8062.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were $8062.0 in Q3 2025, $8877.0 in Q2 2025, and $14650.0 in Q1 2025.